JT
NTGN

Jump Trading’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Jump Trading’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,440
Closed -$67K – 681
2019
Q1 		$67K Buy
+10,440
New +$54.7K 0.02% 514

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Jump Trading's NTGN Position: Q2 2019 in Review

Jump Trading sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2019, closing a stake of 10,440 shares — an estimated $67K sold.

Jump Trading first reported a position in NTGN in Q1 2019 and held it in 1 quarter. The position peaked at $67K in Q1 2019. 51 funds tracked by Wall St. Rank hold NTGN as of Q2 2019.

  • Jump Trading reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Jump Trading sold 10,440 Neon Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $67K.
  • Jump Trading first reported a position in Neon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Jump Trading's Neon Therapeutics, Inc. Common Stock position peaked at $67K in Q1 2019.
  • 51 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.